Live Breaking News & Updates on Institute of medical biology

Stay informed with the latest breaking news from Institute of medical biology on our comprehensive webpage. Get up-to-the-minute updates on local events, politics, business, entertainment, and more. Our dedicated team of journalists delivers timely and reliable news, ensuring you're always in the know. Discover firsthand accounts, expert analysis, and exclusive interviews, all in one convenient destination. Don't miss a beat — visit our webpage for real-time breaking news in Institute of medical biology and stay connected to the pulse of your community

Covid-19 Vaccine: MOH seeking senior citizen volunteers for phase three clinical trial

12 Feb 2021 / 08:11 H.
Pix for representational purpose only.
KUALA LUMPUR: Volunteers aged 60 and above are being sought by the Health Ministry (MOH) to participate in phase three clinical trial of the Covid-19 vaccine.
The Health Ministry (MOH) through its official social media Facebook and Twitter accounts, informed that around 350 to 450 senior citizens were needed for the study which will also test the effectiveness and safety of the vaccine for the group.
“We welcome senior citizens who are interested in contributing to the development of the Covid-19 vaccine,” stated the post.
MOH informed that interested individuals can contact the nine hospitals involved, namely Ampang Hospital, Sarawak General Hospital, Penang Hospital, Seberang Jaya Hospital, Sultanah Bahiyah Hospital, Raja Permaisuri Bainun Hospital, Taiping Hospital, Sungai Buloh Hospital and Sultan Abdul Halim Hospital.

Seberang-jaya , Pulau-pinang , Malaysia , Kuala-lumpur , Taiping , Perak , Ampang , Malaysia-general , Penang , Sungai-buloh , Sultan-abdul-halim , Raja-permaisuri-bainun

Coronavirus Vaccine Mechanism - How Does COVID-19 Vaccine Work?

January 22, 2021
Coronavirus Vaccine Mechanism
Scientists around the world are working around the clock to manufacture a risk-free and effective COVID-19 vaccine. Currently, a handful of vaccines have been approved and are being provided to the public worldwide; a lot more vaccines are under development.
Vaccine development involves various steps to ensure the final product is both safe and efficient. Initially, the fundamental research is carried out, once the vaccine candidate is manufactured, preclinical animal studies are conducted in animal models. Then the vaccine enters small phase 1 studies, focusing on safety, and then larger phase 2 studies, with a focus on efficiency.

Cuba , China , Kazakhstan , India , Munich , Bayern , Germany , London , City-of , United-kingdom , Chinese , Bharat

Xinhua Asia-Pacific news summary at 1600 GMT, Jan. 11

KUALA LUMPUR -- Malaysian Prime Minister Muhyiddin Yassin said Monday that his country will start its first phase 3 clinical trials of COVID-19 vaccines which i

Myanmar , Kuala-lumpur , Malaysia , Yangon , Singapore , China , Padjadjaran , Lampung , Indonesia , Jakarta , Jakarta-raya , Malaysian

Malaysia regulators approve phase 3 trials of Chinese-manufactured COVID-19 vaccine - World News

Malaysia regulators approve phase 3 trials of Chinese-manufactured COVID-19 vaccine - World News
sina.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from sina.com Daily Mail and Mail on Sunday newspapers.

China , Kuala-lumpur , Malaysia , Chinese , Muhyiddin-yassin , Cansino-biologics , Pfizer , Sinovac-biotech , Astrazeneca , Malaysia-national-pharmaceutical-regulatory-agency , World-health , Chinese-academy-of-medical-sciences

Vaccine trials in Malaysia

Dr Akhmal: ‘While we wait for a Covid-19 vaccine to be procured, distributed, and administered to our population, clinical research is an important step to ensure that the vaccine fulfils the requirement of the regulatory authorities which looks at its safety, quality, and efficacy.’
MALAYSIA is now seeing the initiation of the first Covid-19 vaccine trial in the country.
“It is a Phase 3 vaccine trial, by the Institute of Medical Biology, Chinese Academy of Medical Sciences. The trial application is currently ongoing for review and approval by the regulatory authority and ethics committee before being conducted in our hospitals here, ” says Dr Akhmal Yusof, CEO of Clinical Research Malaysia (CRM).

China , Malaysia , Malaysian , Chinese , Muhyiddin-yassin , Dina-murad , Akhmal-yusof , Technology-ministry , Foreign-affairs-ministry , Clinical-research-malaysia , Chinese-academy-of-medical-sciences , Health-ministry